Rx Safety Cmte.’s Holmboe Sees Communication As Key To Risk Management
Executive Summary
Yale University's Eric Holmboe, MD, will be taking his second look at risk-management proposals for GlaxoSmithKline's Lotronex during the inaugural meeting of FDA's Drug Safety & Risk Management Subcommittee